Articles From: Cryptography Research and Tiempo SAS Sign License Agreement for DPA Countermeasures to Dell growth strategy unclear

Cryptography Research, Inc., a division of Rambus Inc. (NASDAQ:RMBS), and Tiempo SAS (Tiempo), experts in designing and qualifying secure smart card chips, today announced they have signed an architecture license agreement allowing for the use of Cryptography Research’s patented security inventions in Tiempo’s integrated circuits.
Sign-up for Cryptography Research and Tiempo SAS Sign License Agreement for DPA Countermeasures investment picks
Sign-up for CSC ServiceWorks Completes Acquisition of Mac-Gray investment picks
BUFFALO, N.Y. , Jan.
Sign-up for CTG Announces Extension of 10b5-1 Plan to Facilitate Share Repurchases investment picks
Sign-up for Ctrip to Hold 2013 Annual General Meeting on October 30, 2013 investment picks
CTS Corporation (NYSE: CTS) announced today that its Board of Directors approved a 14 percent increase of its quarterly cash dividend from $0.035 per share to $0.04 per share.
Sign-up for CTS Corporation Announces 14 Percent Dividend Increase investment picks
Designed to target advanced metastatic renal cell carcinoma, the study will determine the maximum tolerated dose of Debio 0932 in combination with everolimus LAUSANNE , Switzerland and LEXINGTON, Massachusetts , October 22, 2013 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS) , an oncology focused company developing novel, targeted drug candidates for the treatment of human cancers, and Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, including oncology as well as companion diagnostics, today announced the start of an open-label, multicenter Phase I dose-finding study of Debio 0932, a heat shock protein 90 (HSP90) inhibitor in combination with everolimus (Afinitor ® ), an inhibitor of mammalian target of rapamycin (mTOR) in patients with advanced or metastatic renal cell carcinoma (RCC),
Sign-up for Curis and Debiopharm Group™ Announce Initiation of Phase I Dose Finding Clinical Study with a Combination of HSP90 Inhibitor Debio 0932 and Everolimus (Afinitor®) investment picks
Possible Turning Point in International Markets NEW YORK , Oct.
Sign-up for CUSIP Global Services Projects Decline in U.S. Corporate and Muni Bond Issuance investment picks
Carriers love to make claims about whose network is fastest or most reliable.
Sign-up for Customer Data Proves T-Mobile Network Now Fastest 4G LTE in the U.S. investment picks
The Cutwater Select Income Fund (NYSE: CSI) (the “Fund”) declared a dividend of $0.265 on December 4, 2013, payable on January 22, 2014, to shareholders of record at the close of business on December 19, 2013, with a Net Asset Value and New York Stock Exchange ex-dividend date of December 17, 2013 and a comparison date of January 17, 2014.
Sign-up for Cutwater Select Income Fund Declares Quarterly Dividend investment picks
NEW ALBANY, Ohio , Aug.
Sign-up for CVG Announces Realignment Of Executive Leadership Team investment picks
Commits support for law enforcement efforts to safely remove unused prescription drugs from the community Program is part of CVS/pharmacy's on-going commitment to combat prescription drug abuse WOONSOCKET, R.I. , Oct.
Sign-up for CVS/pharmacy Launches National Medication Disposal for Safer Communities Program investment picks
Cypress Semiconductor Corp.
Sign-up for Cypress and D-Wave Systems Announce Successful Transfer Of D-Wave Process Technology to Cypress Foundry investment picks
CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced initiation of a Phase 2 clinical trial with the Company’s aldoxorubicin for the treatment of unresectable glioblastoma multiforme (GBM), a deadly form of brain cancer.
Sign-up for CytRx Initiates Phase 2 Clinical Trial with Aldoxorubicin in Patients with Unresectable Glioblastoma Multiforme (Brain Cancer) investment picks , free news and research website of FXCM Inc (NYSE:FXCM), highlights today some of its new services traders can utilize.
Sign-up for DailyFX Empowers Clients with Educational Resources investment picks
Danaher Corp.
Sign-up for Danaher, Blackstone Working on Bid for J&J's Ortho Unit investment picks
Darden Restaurants Inc. plans to separate its struggling Red Lobster business from the rest of the casual-dining chain as it also said it plans to suspend acquisitions.
Sign-up for Darden to Separate Red Lobster Chain investment picks SAN FRANCISCO, CA and NORTHBROOK, IL --
Sign-up for Data From PREVAIL Trial of Enzalutamide in Chemotherapy-Naive Metastatic Prostate Cancer to Be Presented in Late-Breaking Session at ASCO GU Symposium investment picks SAN FRANCISCO, CA and LONDON, UNITED KINGDOM --
Sign-up for DataSift Unlocks Data Access to World's Second Largest Economy With Sina Weibo investment picks
NEW YORK (MarketWatch) -- Billionaire David Tepper, who runs hedge fund Appaloosa Management LP, told Bloomberg TV that airline stocks is his biggest play.
Sign-up for David Tepper says his big play is airline stocks investment picks
Dealertrack (Nasdaq:TRAK) today announced an agreement to acquire substantially all the assets of Customer Focused Marketing (CFM), Inc., a provider of customer relationship management (CRM) and marketing services.
Sign-up for Dealertrack to Acquire CRM Provider Customer Focused Marketing, Inc. investment picks
Deere Announces Record Fourth-Quarter Earnings of $807 Million Canada NewsWire - Fourth-quarter income rises 17%; earnings per share up 21%. - Full-year earnings reach record $3.54 billion .
Sign-up for Deere Announces Record Fourth-Quarter Earnings of $807 Million investment picks
Deere to sell majority interest in landscapes business to Clayton, Dubilier & Rice Canada NewsWire MOLINE, Ill.
Sign-up for Deere to sell majority interest in landscapes business to Clayton, Dubilier & Rice investment picks
Sign-up for Delaware Life Receives A- Rating Confirmation from A.M. Best investment picks
Dell held its 2013 Annual Meeting of Stockholders today, with shareholders approving the company’s recommended slate of director nominees and voting on three other matters.
Sign-up for Dell Conducts 2013 Annual Meeting of Stockholders investment picks
By MarketWatch SAN FRANCISCO (MarketWatch) -- Dell Inc. didn't really offer a clear explanation on why the company decided to go private, but it's beginning to look that with its current lack of growth prospects, Dell wants to stay out of the public limelight.
Sign-up for Dell growth strategy unclear investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar

Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Cryptography Research and Tiempo SAS Sign License Agreement for DPA Countermeasures to Dell growth strategy unclear
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity